Ontario, CA— (May 08, 2018) – Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or the “Company”), a leading agricultural biotechnology company that develops and manufactures microbial fertilizers for use in the multi-billion food industry is pleased to announce that the Company appointed Mr. Weijun Xu as the Chief Strategy Officer (CSO) of Kiwa Bio-Tech, effective May 3, 2018.
Mr. Xu is an experienced enterprise manager with an impressive track record in strategic investments over the past 20 years. He has served as Director, Secretary, Chief Financial Officer, and General Manager of several public companies, Fortune 500 companies and China’s top 500 enterprises. Mr. Xu holds a Bachelor degree in International Accounting from Shanghai Jiaotong University.
The CEO of Kiwa Bio-Tech Products Group Corp. states, “We are extremely happy to welcome Mr. Xu to the Company. His native experiences and global perspectives go hand in hand, which could contribute to Kiwa Bio-Tech’s development in the local area. Mr. Xu has extensive expertise and experience in capital markets, and can help the Company realize the long-term strategic planning. Mr. Xu will be responsible for the investment management, strategic planning, business innovation, and capability improvement for the Company. As we tap into the boundless potential of Kiwa Bio-Tech, we could speed up our process to keep up with the agricultural companies on the NYSE and Nasdaq.”
About Kiwa Bio-Tech Products Group Corp.
Leader in Eco-friendly Agricultural Industry Chain
Kiwa Bio-Tech Products Group Corp. (KWBT) is a publicly traded company with corporate headquarters in the United States. The company develops, manufacture, markets and distributes innovative and environmentally safe bio-technological products for agriculture. Kiwa’s focus is to positively impact the environment by reducing the amount of chemicals that are being used by agricultural growers in China.
Kiwa Bio-Tech Products Group corp. products are covered by patent protection and are designed to enhance the quality of human life by increasing the value and productivity of agricultural crops.
For more information on Kiwa Bio-Tech Products Group Corp. or its bio-fertilizer products and smart soil remediation technology, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission at www.sec.gov.
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release
Contact:
Kiwa Bio-Tech Products Group Corporation
Molly Han
Investor & Media Relations
Tel: 909-456-8828
